Site NM-404 — High Desert Clinical Research

Albuquerque, NM · Southwest · PI Dr. Elias Moreno · Coordinator Kara Lindqvist

Activation PendingHigh100
← Back to trial dashboard

Activation Readiness

IRB / Ethics approvalNot Started
Regulatory documents4/10 complete
Investigator trainingNot Started
Staff trainingNot Started
ContractSubmitted
BudgetPending
Planned activation2026-09-28 (in 38 days)

Enrollment

0of 20 patients (0%)
Enrollment rate0 patients / month
StatusNot started

Operations

Data entryNot Started
Open data queries0
Protocol deviations0
Outstanding tasks11
Last site activity16 days ago
Last monitoring visitNot yet visited

Agent Assessment

High
Risk score
100/100
Why am I seeing this?

NM-404 was classified as High Risk because irb approval not started, 6 required regulatory documents missing, investigator training not started.

Primary risk factors
  • IRB approval not started+32 · Regulatory
    IRB record is "Not Started" — the site cannot enroll patients in this state.
    Source: Regulatory Document Repository
  • 6 required regulatory documents missing+30 · Regulatory
    4/10 essential documents are on file.
    Source: Regulatory Document Repository
  • Investigator training not started+18 · Training
    Protocol training for the principal investigator is not complete.
    Source: Site Training Records (LMS)
  • Site staff training not started+14 · Training
    Coordinator/staff protocol training is not complete.
    Source: Site Training Records (LMS)
  • Clinical trial agreement submitted+12 · Regulatory
    Executed contract is required prior to activation.
    Source: CTMS contract record
  • No site activity for 16 days+12 · Engagement
    Site has not logged activity in CTMS recently.
    Source: CTMS activity log
  • Budget pending+8 · Regulatory
    Site budget approval is outstanding.
    Source: CTMS budget record
Recommended action

Contact Site Coordinator Kara Lindqvist regarding the outstanding IRB approval and 6 missing regulatory documents.

Agent actions for this site

No actions prepared yet for NM-404 in trial CT-2026-301.